Compare $LTRN vs $TPST | Chartloom

Compare

$LTRN vs $TPST

Lantern Pharma Inc · Tempest Therapeutics Inc

LTRN

Lantern Pharma Inc

TPST

Tempest Therapeutics Inc

Compare $LTRN vs $TPST

Comparing Lantern Pharma Inc and Tempest Therapeutics Inc

LTRNLantern Pharma Inc

TPSTTempest Therapeutics Inc

LTRNLantern Pharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.9%

52W performance

-82.3%

FCF yield

-135.8%

TPSTTempest Therapeutics Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-6.3%

YTD performance

-74.2%

52W performance

-93.1%

FCF yield

-170.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LTRN

TPST

Detailed metrics comparison

LTRN

Lantern Pharma Inc

TPST

Tempest Therapeutics Inc

Market Cap

LTRN$10M

TPST$12M

Enterprise Value

LTRN$4M

TPST$11M

Price

LTRN$0.81

TPST$0.76

P/E Ratio

LTRNN/A

TPSTN/A

P/S Ratio

LTRN0.00x

TPST45.67x

EV/Sales

LTRN0.00x

TPST43.07x

EV/EBITDA

LTRN0.00x

TPST0.00x

P/B Ratio

LTRN3.19x

TPST16.67x

P/FCF Ratio

LTRNN/A

TPSTN/A

EV/FCF

LTRN-0.26x

TPST-0.55x

PEG Ratio

LTRNN/A

TPSTN/A

Forward P/E (NTM)

LTRNN/A

TPSTN/A

Forward P/S (NTM)

LTRNN/A

TPSTN/A

Revenue (TTM)

LTRN$0

TPST$0

Revenue Growth (YoY)

LTRNN/A

TPST-6.3%

Forward Rev Growth

LTRN0.0%

TPST0.0%

Gross Margin (TTM)

LTRN0.0%

TPST0.0%

Operating Margin (TTM)

LTRN0.0%

TPST0.0%

EBITDA Margin (TTM)

LTRN0.0%

TPST0.0%

Net Margin (TTM)

LTRN0.0%

TPST0.0%

FCF Margin (TTM)

LTRNN/A

TPSTN/A

Net Income (TTM)

LTRN$-19M

TPST$-40M

FCF (TTM)

LTRN$-14M

TPST$-21M

EPS (TTM)

LTRN-$1.50

TPST-$2.66

ROE (TTM)

LTRN-19835.0%

TPST-72989.0%

ROA (TTM)

LTRN-18428.0%

TPST-29736.0%

ROIC (TTM)

LTRN-19835.0%

TPST-72989.0%

Cash

LTRN$7M

TPST$779K

Debt

LTRN$0

TPST$0

Net Cash/Debt

LTRN$7M

TPST$779K

Current Ratio (TTM)

LTRN1.96x

TPST0.38x

Quick Ratio (TTM)

LTRN1.70x

TPST0.27x

Debt/Equity (TTM)

LTRN0.00x

TPST0.00x

Debt/Assets (TTM)

LTRN0.0%

TPST0.0%

Interest Coverage (TTM)

LTRNN/A

TPSTN/A

Net Debt/EBITDA (TTM)

LTRN0.00x

TPST0.00x

Beta

LTRN2.42

TPST-1.61

52W Performance

LTRN-82.3%

TPST-93.1%

YTD Performance

LTRN-73.9%

TPST-74.2%

% from 52W High

LTRN-82.7%

TPST-93.8%

% from 52W Low

LTRN6.9%

TPST2.3%

Asset Turnover (TTM)

LTRN0.00x

TPST0.01x

FCF Yield (TTM)

LTRN-135.8%

TPST-170.7%

Earnings Yield (TTM)

LTRN-179.9%

TPST-333.2%

Dividend Yield (TTM)

LTRNN/A

TPSTN/A

Rule of 40

LTRN0.0

TPST-6.3

EV/GP/RG

LTRNN/A

TPSTN/A

Ticker research

View LTRN research View TPST research

Metric	LTRN Lantern Pharma Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$10M	$12M
Enterprise Value	$4M	$11M
Price	$0.81	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	45.67x
EV/Sales	0.00x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.19x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.26x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-19M	$-40M
FCF (TTM)	$-14M	$-21M
EPS (TTM)	-$1.50	-$2.66
ROE (TTM)	-19835.0%	-72989.0%
ROA (TTM)	-18428.0%	-29736.0%
ROIC (TTM)	-19835.0%	-72989.0%
Financial Health
Cash	$7M	$779K
Debt	$0	$0
Net Cash/Debt	$7M	$779K
Current Ratio (TTM)	1.96x	0.38x
Quick Ratio (TTM)	1.70x	0.27x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	-1.61
52W Performance	-82.3%	-93.1%
YTD Performance	-73.9%	-74.2%
% from 52W High	-82.7%	-93.8%
% from 52W Low	6.9%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-135.8%	-170.7%
Earnings Yield (TTM)	-179.9%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View LTRN research	View TPST research

Valuation

P/S Ratio

LTRN

0.00x

TPST

45.67x

EV/FCF

TPST

-0.55x

LTRN

-0.26x

Growth & revenue

Revenue Growth TTM

TPST

-6.3%

Forward Revenue Growth

LTRN

0.0%

TPST

0.0%

Profitability & performance

Gross Margin

LTRN

0.0%

TPST

0.0%

ROE

LTRN

-19835.0%

TPST

-72989.0%

FCF Yield %

LTRN

-135.8%

TPST

-170.7%

52-Week Performance

LTRN

-82.3%

TPST

-93.1%

Detailed metrics comparison

LTRN

Lantern Pharma Inc

TPST

Tempest Therapeutics Inc

Market Cap

LTRN$10M

TPST$12M

Enterprise Value

LTRN$4M

TPST$11M

Price

LTRN$0.81

TPST$0.76

P/E Ratio

LTRNN/A

TPSTN/A

P/S Ratio

LTRN0.00x

TPST45.67x

EV/Sales

LTRN0.00x

TPST43.07x

EV/EBITDA

LTRN0.00x

TPST0.00x

P/B Ratio

LTRN3.19x

TPST16.67x

P/FCF Ratio

LTRNN/A

TPSTN/A

EV/FCF

LTRN-0.26x

TPST-0.55x

PEG Ratio

LTRNN/A

TPSTN/A

Forward P/E (NTM)

LTRNN/A

TPSTN/A

Forward P/S (NTM)

LTRNN/A

TPSTN/A

Revenue (TTM)

LTRN$0

TPST$0

Revenue Growth (YoY)

LTRNN/A

TPST-6.3%

Forward Rev Growth

LTRN0.0%

TPST0.0%

Gross Margin (TTM)

LTRN0.0%

TPST0.0%

Operating Margin (TTM)

LTRN0.0%

TPST0.0%

EBITDA Margin (TTM)

LTRN0.0%

TPST0.0%

Net Margin (TTM)

LTRN0.0%

TPST0.0%

FCF Margin (TTM)

LTRNN/A

TPSTN/A

Net Income (TTM)

LTRN$-19M

TPST$-40M

FCF (TTM)

LTRN$-14M

TPST$-21M

EPS (TTM)

LTRN-$1.50

TPST-$2.66

ROE (TTM)

LTRN-19835.0%

TPST-72989.0%

ROA (TTM)

LTRN-18428.0%

TPST-29736.0%

ROIC (TTM)

LTRN-19835.0%

TPST-72989.0%

Cash

LTRN$7M

TPST$779K

Debt

LTRN$0

TPST$0

Net Cash/Debt

LTRN$7M

TPST$779K

Current Ratio (TTM)

LTRN1.96x

TPST0.38x

Quick Ratio (TTM)

LTRN1.70x

TPST0.27x

Debt/Equity (TTM)

LTRN0.00x

TPST0.00x

Debt/Assets (TTM)

LTRN0.0%

TPST0.0%

Interest Coverage (TTM)

LTRNN/A

TPSTN/A

Net Debt/EBITDA (TTM)

LTRN0.00x

TPST0.00x

Beta

LTRN2.42

TPST-1.61

52W Performance

LTRN-82.3%

TPST-93.1%

YTD Performance

LTRN-73.9%

TPST-74.2%

% from 52W High

LTRN-82.7%

TPST-93.8%

% from 52W Low

LTRN6.9%

TPST2.3%

Asset Turnover (TTM)

LTRN0.00x

TPST0.01x

FCF Yield (TTM)

LTRN-135.8%

TPST-170.7%

Earnings Yield (TTM)

LTRN-179.9%

TPST-333.2%

Dividend Yield (TTM)

LTRNN/A

TPSTN/A

Rule of 40

LTRN0.0

TPST-6.3

EV/GP/RG

LTRNN/A

TPSTN/A

Ticker research

View LTRN research View TPST research

Metric	LTRN Lantern Pharma Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$10M	$12M
Enterprise Value	$4M	$11M
Price	$0.81	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	45.67x
EV/Sales	0.00x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.19x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.26x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-19M	$-40M
FCF (TTM)	$-14M	$-21M
EPS (TTM)	-$1.50	-$2.66
ROE (TTM)	-19835.0%	-72989.0%
ROA (TTM)	-18428.0%	-29736.0%
ROIC (TTM)	-19835.0%	-72989.0%
Financial Health
Cash	$7M	$779K
Debt	$0	$0
Net Cash/Debt	$7M	$779K
Current Ratio (TTM)	1.96x	0.38x
Quick Ratio (TTM)	1.70x	0.27x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	-1.61
52W Performance	-82.3%	-93.1%
YTD Performance	-73.9%	-74.2%
% from 52W High	-82.7%	-93.8%
% from 52W Low	6.9%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-135.8%	-170.7%
Earnings Yield (TTM)	-179.9%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View LTRN research	View TPST research